|
Completed
|
NCT02497131 -
Study on the Role of Brentuximab Vedotin as Single Agent in the Treatment of Relapsed/Refractory CD30+ PTCL Patients
|
Phase 2 |
|
Recruiting
|
NCT01451502 -
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
|
N/A |
|
Active, not recruiting
|
NCT03264131 -
BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma
|
Phase 2 |
|
Completed
|
NCT03744676 -
A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting (TRANSCEND-OUTREACH-007)
|
Phase 2 |
|
Completed
|
NCT02335242 -
Sildenafil for the Treatment of Lymphatic Malformations
|
Phase 2 |
|
Completed
|
NCT03135535 -
Micro-mobile Foot Compression and Diabetic Foot
|
Phase 2 |
|
Active, not recruiting
|
NCT05441943 -
Lymphaticovenous Anastomosis as Treatment for Lymphedema
|
N/A |
|
Recruiting
|
NCT06267807 -
Lymphatic Phenotype in Noonan Syndrome Spectrum Disorders
|
N/A |
|
Withdrawn
|
NCT05431179 -
A Study of Zilovertamab and Ibrutinib in Patients With Relapsed or Refractory Mantle Cell Lymphoma
|
Phase 3 |
|
Recruiting
|
NCT05731141 -
A Prospective Natural History Study of Lymphatic Anomalies
|
|
|
Recruiting
|
NCT03696784 -
Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma
|
Phase 1 |
|
Completed
|
NCT03709407 -
"Effects of Manual Lymphatic Drainage in the Neck in Healthy Subjects. Experimental Randomized Crossover Study"
|
N/A |
|
Active, not recruiting
|
NCT02663297 -
Administration of T Lymphocytes for Prevention of Relapse of Lymphomas
|
Phase 1 |
|
Completed
|
NCT02960841 -
Effectiveness of Intracavitary Manual Lymphatic Drainage
|
Phase 4 |
|
Recruiting
|
NCT05263583 -
Sepantronium Bromide for the Treatment of High-grade B-cell Lymphoma
|
Phase 2 |
|
Terminated
|
NCT02499627 -
Bendamustine Plus Brentuximab Vedotin in HL and CD30+ PTCL in First Salvage Setting
|
Phase 2 |
|
Recruiting
|
NCT03373019 -
Chidamide Combined With R-GDP in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
|
Phase 2 |
|
Recruiting
|
NCT03602157 -
Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL
|
Phase 1 |
|
Recruiting
|
NCT02690545 -
Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL
|
Phase 1/Phase 2 |
|
Completed
|
NCT02744027 -
Imaging of Lymphatic Anomalies
|
N/A |